Israeli-American AEYE Health Wins Prestigious Prix Galien Award for AI Blindness Prevention Tech
Summarized from The Jerusalem Post by baba
Israeli-American company AEYE Health won the 2026 Prix Galien USA Award for its AI technology, AEYE-DS, which helps prevent blindness from diabetic retinopathy. The system provides accessible, AI-driven diabetic eye exams, overcoming barriers of traditional specialist screenings. The company is now developing a new platform, AEYE-X, to assess over 100 health conditions using retinal images.
The story in 5 lines · by baba
- AEYE Health won the 2026 Prix Galien USA Award for its AI blindness prevention technology.
- The AEYE-DS technology provides accessible, AI-driven diabetic eye exams to prevent blindness.
- Diabetic retinopathy is the leading cause of blindness among working-age adults.
- The system uses AI and retinal cameras for immediate diagnostic results without physician interpretation.
- AEYE Health is developing a new platform, AEYE-X, for broader health assessments from retinal images.
The Jerusalem Post publishes in English. The key points are summarized above. Read The Jerusalem Post’s full report from the link at the top of the page.
Mentioned
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.